182 related articles for article (PubMed ID: 31897811)
1. GATA1-regulated JAG1 promotes ovarian cancer progression by activating Notch signal pathway.
Liu Z; Zhu Y; Li F; Xie Y
Protoplasma; 2020 May; 257(3):901-910. PubMed ID: 31897811
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro effects of microRNA-124 on human gastric cancer by targeting JAG1 through the Notch signaling pathway.
Xiao HJ; Ji Q; Yang L; Li RT; Zhang C; Hou JM
J Cell Biochem; 2018 Mar; 119(3):2520-2534. PubMed ID: 28941308
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer.
Liu MX; Siu MK; Liu SS; Yam JW; Ngan HY; Chan DW
Oncotarget; 2014 Feb; 5(4):944-58. PubMed ID: 24659709
[TBL] [Abstract][Full Text] [Related]
4. Lysine demethylase 2A promotes stemness and angiogenesis of breast cancer by upregulating Jagged1.
Chen JY; Li CF; Chu PY; Lai YS; Chen CH; Jiang SS; Hou MF; Hung WC
Oncotarget; 2016 May; 7(19):27689-710. PubMed ID: 27029061
[TBL] [Abstract][Full Text] [Related]
5. The oncogenic role of Jagged1/Notch signaling in cancer.
Xiu MX; Liu YM; Kuang BH
Biomed Pharmacother; 2020 Sep; 129():110416. PubMed ID: 32593969
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-377-3p inhibits growth and invasion through sponging JAG1 in ovarian cancer.
Tang L; Yang B; Cao X; Li Q; Jiang L; Wang D
Genes Genomics; 2019 Aug; 41(8):919-926. PubMed ID: 31041680
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicle-carried Jagged-1 inhibits HUVEC sprouting in a 3D microenvironment.
Tan E; Asada HH; Ge R
Angiogenesis; 2018 Aug; 21(3):571-580. PubMed ID: 29541959
[TBL] [Abstract][Full Text] [Related]
8. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L
Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of Notch 3 gene expression in ovarian serous carcinoma.
Jung SG; Kwon YD; Song JA; Back MJ; Lee SY; Lee C; Hwang YY; An HJ
Cancer Sci; 2010 Sep; 101(9):1977-83. PubMed ID: 20624166
[TBL] [Abstract][Full Text] [Related]
10. The Long Non-Coding RNA MALAT1 Enhances Ovarian Cancer Cell Stemness by Inhibiting YAP Translocation from Nucleus to Cytoplasm.
Wu X; Wang Y; Zhong W; Cheng H; Tian Z
Med Sci Monit; 2020 May; 26():e922012. PubMed ID: 32433460
[TBL] [Abstract][Full Text] [Related]
11. Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.
Nishina S; Shiraha H; Nakanishi Y; Tanaka S; Matsubara M; Takaoka N; Uemura M; Horiguchi S; Kataoka J; Iwamuro M; Yagi T; Yamamoto K
Oncol Rep; 2011 Sep; 26(3):523-31. PubMed ID: 21637926
[TBL] [Abstract][Full Text] [Related]
12. TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.
Escalona RM; Bilandzic M; Western P; Kadife E; Kannourakis G; Findlay JK; Ahmed N
BMC Cancer; 2020 Oct; 20(1):960. PubMed ID: 33023532
[TBL] [Abstract][Full Text] [Related]
13. Akt-activated endothelium promotes ovarian cancer proliferation through notch activation.
Hoarau-Véchot J; Touboul C; Halabi N; Blot-Dupin M; Lis R; Abi Khalil C; Rafii S; Rafii A; Pasquier J
J Transl Med; 2019 Jun; 17(1):194. PubMed ID: 31182109
[TBL] [Abstract][Full Text] [Related]
14. The antitumor function of arctigenin in human retinoblastoma cells is mediated by jagged‑1.
Ke N; Liu Q; Pi L; Fang J; Chen L; Chen X
Mol Med Rep; 2019 May; 19(5):3642-3648. PubMed ID: 30896794
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer.
Shimizu M; Cohen B; Goldvasser P; Berman H; Virtanen C; Reedijk M
Cancer Res; 2011 Jan; 71(1):277-86. PubMed ID: 21199807
[TBL] [Abstract][Full Text] [Related]
16. Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer.
Tang W; Ren A; Xiao H; Sun H; Li B
Biomed Pharmacother; 2017 Jan; 85():248-255. PubMed ID: 27908706
[TBL] [Abstract][Full Text] [Related]
17. Association of Jagged1 expression with malignancy and prognosis in human pancreatic cancer.
Lee J; Lee J; Kim JH
Cell Oncol (Dordr); 2020 Oct; 43(5):821-834. PubMed ID: 32483746
[TBL] [Abstract][Full Text] [Related]
18. Development of Therapeutic Anti-JAGGED1 Antibodies for Cancer Therapy.
Masiero M; Li D; Whiteman P; Bentley C; Greig J; Hassanali T; Watts S; Stribbling S; Yates J; Bealing E; Li JL; Chillakuri C; Sheppard D; Serres S; Sarmiento-Soto M; Larkin J; Sibson NR; Handford PA; Harris AL; Banham AH
Mol Cancer Ther; 2019 Nov; 18(11):2030-2042. PubMed ID: 31395687
[TBL] [Abstract][Full Text] [Related]
19. High expression of the Notch ligand Jagged-1 is associated with poor prognosis after surgery for colorectal cancer.
Sugiyama M; Oki E; Nakaji Y; Tsutsumi S; Ono N; Nakanishi R; Sugiyama M; Nakashima Y; Sonoda H; Ohgaki K; Yamashita N; Saeki H; Okano S; Kitao H; Morita M; Oda Y; Maehara Y
Cancer Sci; 2016 Nov; 107(11):1705-1716. PubMed ID: 27589478
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
